{"value":{"id":1936588,"askingMemberId":4174,"askingMember":null,"house":"Lords","memberHasInterest":false,"dateTabled":"2026-09-01T00:00:00","dateForAnswer":"2026-09-15T00:00:00","uin":"HL2955","questionText":"To ask His Majesty's Government what steps they are taking to ensure consistent and equitable access to pharmacological interventions for overweight and obesity recommended in National Institute for Health and Care Excellence guideline NG246; and how they are monitoring compliance with this guideline across all Integrated Care Systems in England.","answeringBodyId":17,"answeringBodyName":"Department of Health and Social Care","isWithdrawn":false,"isNamedDay":false,"groupedQuestions":[],"answerIsHolding":false,"answerIsCorrection":false,"answeringMemberId":347,"answeringMember":null,"correctingMemberId":null,"correctingMember":null,"dateAnswered":"2026-09-09T00:00:00","answerText":"<p>I refer the Noble Baroness to the answer provided in the House of Commons on 2 June 2026 in response to Question <a href=\"https://questions-statements.parliament.uk/written-questions/detail/2026-05-19/2751\" target=\"_blank\">2751</a> which, for ease of reference, is reproduced below.</p><p>Integrated care boards (ICBs) are legally required to make funding available for medicines recommended by the National Institute for Health and Care Excellence (NICE) in line with NICE guidance and the NICE Funding Variation for tirzepatide.</p><p>NHS England is supporting ICBs to implement local pathways for the assessment, prescribing, and management of tirzepatide, and has centrally commissioned wraparound support for eligible patients. It has also provided additional funding in 2025/26 and 2026/27 to support towards the cost of prescribing weight loss medicines. From 2026/27, NHS England has introduced new Quality and Outcomes Framework indicators, with additional funding to support implementation of obesity medicine pathways in primary care.</p><p>NHS England monitors implementation through routine engagement with systems. There are currently no plans for NHS England to review the methodology used to allocate funding to ICBs for these services.</p>","originalAnswerText":"","comparableAnswerText":"","dateAnswerCorrected":null,"dateHoldingAnswer":null,"attachmentCount":0,"heading":"Obesity: Drugs","attachments":[],"groupedQuestionsDates":[]},"links":[{"rel":"self","href":"/Questions/1936588","method":"GET"}]}